Navigation Links
Neue Studie kommt zu dem Schluss, dass manche Patienten mit Refluxkrankheit von Stretta eher profitieren als von chronischer Behandlung mit Protonenpumpenhemmern oder Antireflux-Operation
Date:9/6/2013

bei Refluxkrankheit und eine wirksame Alternative bei Patienten, die nicht gut auf Medikamente ansprechen. Stretta gibt Hochfrequenzenergie an den unteren Schließmuskel der Speiseröhre und den Mageneingang ab. Studien zeigen, dass Stretta eine sichere, wirksame und lang anhaltende Therapiealternative ist. Stretta schließt weitere Behandlungsschritte mit invasiveren Verfahren nicht aus, wenn diese angezeigt sind. Stretta wird derzeit von vielen Krankenversicherungen bezahlt.

ÜBER MEDERI®

Mederi Therapeutics produziert und vertreibt innovative Medizinprodukte, die Erkrankungen des Verdauungssystems mit Hochfrequenzenergie behandeln. Die von Mederi angebotenen Therapiemethoden sind minimalinvasiv, werden ambulant durchgeführt und fördern eine schnelle Heilung.

Kontakt: Julia Brannan
+1-908-464-2470
julia@pascalecommunications.com


'/>"/>
SOURCE Mederi Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Free Download: Two Impressive Case Studies on Drug Delivery Discoveries
2. National Pharmaceutical Council Studies New Formulary Decision-Making Tool
3. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
4. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
5. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
9. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
10. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
11. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... VILLAGE, Nev. , June 29, 2015  PDL ... it has entered into a credit agreement with CareView ... with up to $40 million of secured debt financing. ... industry focused on patient care monitoring. Under ... to $40 million of debt financing in two tranches ...
(Date:6/29/2015)... NESS ZIONA, Israel , ... Ltd. (Nasdaq: BVXV, TASE: BVXV) today announced positive preliminary ... M-001, BiondVax,s candidate for a universal influenza vaccine. In ... the ages of 50 to 65, followed by an ... 3 weeks later. M-001 was found to be safe ...
(Date:6/29/2015)... , June 29, 2015 DURECT ... James E. Brown , President and CEO, ... Conference on Wednesday, July 8 at 11:45 a.m. ... Le Parker Meridien Hotel in New York City.  ... may request a one-on-one meeting through the conference ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3DURECT to Present at the Cantor Fitzgerald Healthcare Conference 2
... risk of,stroke by 34% in patient with atrial fibrillation or ... adequately treated by antithrombotic ... a,post-hoc analysis of the data from the ATHENA study were ... Society of Cardiology,congress 2008, in Munich, Germany. Previous results from ...
... in Subjects with ALS, RICHMOND, Calif., Sept. 3 ... that it has opened a Phase,2 clinical trial (SB-509-801) ... progressive, degenerative motor-neuron disease for which there,are limited treatment ... an injectable formulation of a plasmid,encoding a zinc finger ...
Cached Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5
(Date:6/30/2015)... ... June 30, 2015 , ... The Citizens ... Danny Davis (D-IL) for writing to the Department of Health and Human Services ... behavioral healthcare system, Universal Health Services (UHS).[1] CCHR is expanding its seven-year review ...
(Date:6/30/2015)... Lewisberry, PA (PRWEB) , ... June 30, 2015 , ... Due to today’s housing market, ... a little more difficult as they have to make adjustments as to how to carry ... of today’s homes have laundry facilities in the basement or first floor of the home, ...
(Date:6/30/2015)... Arbor, MI (PRWEB) , ... June 30, 2015 , ... ... decision support tool to That Neighborhood Foundation for use in That Neighborhood Free Health ... providers at the clinic with building and broadening differential diagnosis and expanding their perspective ...
(Date:6/30/2015)... ... June 30, 2015 , ... When it comes to volunteering abroad, not ... associated costs will be too high. However, there are affordable programs to be had ... experience at minimal cost. One such volunteer named Uzma Aishah, a student at the ...
(Date:6/30/2015)... ... 2015 , ... Some may define success as the sum of small efforts ... State Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and applauded ... a number of members also received honors at the national level. , ...
Breaking Medicine News(10 mins):Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3
... will report its financial results for the three and six ... Thursday, January 8, 2009.,At 4:30 PM Eastern Standard Time on ... webcast to discuss the company,s earnings and other,information. , ... , The earnings announcement ...
... WASHINGTON, Dec. 16 On Wednesday, December 17th Governor ... Institutes of Health Summit: The Science of Eliminating Health ... be held in conjunction with the National Center on ... the summit is to increase awareness and understanding of ...
... brain damage after attack , , TUESDAY, Dec. 16 (HealthDay News) ... carbon monoxide (CO) may help prevent brain damage after a ... odorless gas that can cause organ damage and death, is ... systems, vehicles and gas ranges. In enclosed or semi-enclosed places ...
... seen after 30 years of smoking, researchers say, , , TUESDAY, ... list of cancers caused by smoking, Italian researchers report that ... as is the risk of dying from that disease. ... about 18 percent and the risk of dying from the ...
... , , SOMERVILLE, N.J., ... company, today announced the launch of the PROCEED Ventral ... of hernia products. PVP Device is the first and ... exclusive, absorbable deployment technology. It is indicated for use ...
... Commitment of $3 million through 2011 to the Partnership for ... improve care , , PHILADELPHIA, ... will extend its support for the Partnership for Patient Care, ... hospitals, with funding of $3 million through 2011. The funding ...
Cached Medicine News:Health News:Allscripts to Announce Fiscal Second Quarter Results on January 8, 2009 2Health News:Allscripts to Announce Fiscal Second Quarter Results on January 8, 2009 3Health News:Allscripts to Announce Fiscal Second Quarter Results on January 8, 2009 4Health News:Small Doses of Carbon Monoxide Might Help Stroke Victims 2Health News:Smoking Ups Colon Cancer Risk 2Health News:Smoking Ups Colon Cancer Risk 3Health News:ETHICON Launches the Latest Innovation in Hernia Repair Platform; PROCEED(TM) Ventral Patch (PVP(TM) Device) 2Health News:Independence Blue Cross Extends Funding to Enhance Patient Safety at Area Hospitals 2Health News:Independence Blue Cross Extends Funding to Enhance Patient Safety at Area Hospitals 3
Inquire...
... three styles. Each style has multiple sizes. ... popular style. Pectoral Implants are available non-sterile ... individually, not in pairs. Both styles are ... for a specific side and are directional. ...
... In vivo results may be affected by the ... scar tissue can impact the desired augment-ation 1 ... from patient to patient. Implant dimensions can be ... surgical scissors. All dimensions in centimeters. This device ...
... IQmark family elevates your ECG and Spirometry capabilities ... and efficient patient care. The IQmark Diagnostic PDA ... clinics and medical centers as well as for ... conjunction with the IQmark Digital ECG PDA and ...
Medicine Products: